Search Login Register

Obesity Summary

Description: A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Key Drugs and Agents for Obesity

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Insulin (Novolin) : 259 outcomes 630 studies in 6041 results : FDA 2
  2. Glucose (Dextrose) : 204 outcomes 538 studies in 4801 results : FDA 175 Generic
  3. Leptin : 81 outcomes 461 studies in 3743 results : IBA
  4. Carbon Monoxide : 62 outcomes 137 studies in 1328 results : IBA
  5. Adiponectin : 48 outcomes 194 studies in 1543 results : IBA
  6. Hormones : 41 outcomes 158 studies in 1712 results : IBA
  7. Cholesterol : 40 outcomes 138 studies in 1777 results : IBA
  8. orlistat (Xenical) : 33 outcomes 39 studies in 300 results : FDA 2
  9. sibutramine (Meridia) : 27 outcomes 42 studies in 278 results : FDA 1
  10. Blood Glucose (Blood Sugar) : 25 outcomes 56 studies in 559 results : IBA
Show All >>

Diseases Related to Obesity

  1. Weight Loss (Weight Reduction)
  2. Insulin Resistance
  3. Hypertension (High Blood Pressure)
  4. Inflammation
  5. Body Weight (Weight, Body)
Show All >>

Key Therapies for Obesity

Efficacy Chart >>
  1. Bariatric Surgery : 202 outcomes 113 studies in 1446 results
  2. Gastric Bypass (Roux-en-Y Gastric Bypass) : 69 outcomes 60 studies in 597 results
  3. Drug Therapy (Chemotherapy) : 32 outcomes 62 studies in 676 results
  4. Caloric Restriction : 18 outcomes 30 studies in 312 results
  5. Gastrectomy : 18 outcomes 23 studies in 210 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.